The purpose of this study is to compare the neuropsychological profile of patients affected by
parkinsonism and vascular lesions to that in patients with PD alone (PD) and to evaluate …

Background Identifying individuals at risk of developing Parkinson's disease (PD) is critical
to define target populations for future neuroprotective trials. Objective The objective of this …

The objective of this work was to evaluate the Movement Disorders Society (MDS) Task
Force–proposed screening checklist for detecting Parkinson's disease dementia (PD‐D) in …

Objective The objective of this study was to identify clinical predictors of motor complications
(dyskinesia and motor fluctuations) of levodopa in a prospectively recruited PD cohort using …

Introduction Younger age of onset and mild cognitive impairment (MCI) are both
independently associated with poorer quality of life (QOL) in Parkinson's disease (PD) …

Background The authors studied the measurement properties of the Parkinson's Disease‐
Cognitive Rating Scale (PD‐CRS) compared with Movement Disorders Society Task Force …

Mild cognitive impairment is increasingly recognized as a construct in Parkinson's disease
(PD) and occurs in about 25% of nondemented PD patients. Although executive dysfunction …

Olfactory deficits and executive dysfunction are early and common symptoms in Parkinson's
disease (PD). Previous studies have shown that hyposmia can be a first sign of PD. The aim …

The aim of this study was to establish the rate of progression from mild cognitive impairment
(MCI) to dementia in patients with Parkinson's disease (PD). PD patients without dementia …

Background Cognitive deficits considerably contribute to the patient's burden in Parkinson's
disease (PD). While cognitive decline is linked to neuronal dysfunction, the additional role of …